−275.77 M HKD
0.00 HKD
About VISEN PHARMACEUTICALS
Sector
Industry
CEO
An Bang Lu
Website
Headquarters
Suzhou
Founded
2018
FIGI
BBG01STBC329
VISEN Pharmaceuticals operates as a biopharmaceutical company. It focuses on developing therapies and patient-centric care on endocrine diseases. The firm operates a segment which is developing and commercializing paradigm-shifting endocrine therapies in Greater China. The company was founded on November 1, 2018 and is headquartered in Suzhou, China.
Related stocks
Frequently Asked Questions
The current price of 2561 is 54.35 HKD — it has increased by 4.57% in the past 24 hours. Watch VISEN PHARMACEUTICALS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange VISEN PHARMACEUTICALS stocks are traded under the ticker 2561.
2561 stock has fallen by −16.79% compared to the previous week, the month change is a −16.79% fall, over the last year VISEN PHARMACEUTICALS has showed a −21.00% decrease.
2561 reached its all-time high on Mar 21, 2025 with the price of 69.15 HKD, and its all-time low was 50.25 HKD and was reached on Mar 27, 2025. View more price dynamics on 2561 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track VISEN PHARMACEUTICALS financials in yearly and quarterly reports right on TradingView.
No, 2561 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 2561 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VISEN PHARMACEUTICALS stock right from TradingView charts — choose your broker and connect to your account.